Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam for RBD in Parkinson's Disease
NCT02312908Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clonazepam in REM sleep behavior disorder (RBD), sponsored by Seoul National University Hospital. Started Mar 2015; status: completed.
02
Drugs
clonazepam
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT02312908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312908.